Citation
Huang, Yi, et al. "Simultaneous Quantification of Vortioxetine, Carvedilol and Its Active Metabolite 4-hydroxyphenyl Carvedilol in Rat Plasma By UPLC-MS/MS: Application to Their Pharmacokinetic Interaction Study." Journal of Pharmaceutical and Biomedical Analysis, vol. 128, 2016, pp. 184-190.
Huang Y, Zheng S, Pan Y, et al. Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC-MS/MS: Application to their pharmacokinetic interaction study. J Pharm Biomed Anal. 2016;128:184-190.
Huang, Y., Zheng, S., Pan, Y., Li, T., Xu, Z. S., & Shao, M. M. (2016). Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC-MS/MS: Application to their pharmacokinetic interaction study. Journal of Pharmaceutical and Biomedical Analysis, 128, 184-190. https://doi.org/10.1016/j.jpba.2016.05.029
Huang Y, et al. Simultaneous Quantification of Vortioxetine, Carvedilol and Its Active Metabolite 4-hydroxyphenyl Carvedilol in Rat Plasma By UPLC-MS/MS: Application to Their Pharmacokinetic Interaction Study. J Pharm Biomed Anal. 2016 Sep 5;128:184-190. PubMed PMID: 27262994.
TY - JOUR
T1 - Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC-MS/MS: Application to their pharmacokinetic interaction study.
AU - Huang,Yi,
AU - Zheng,Shuangli,
AU - Pan,Yongyang,
AU - Li,Tao,
AU - Xu,Zhi-Sheng,
AU - Shao,Meng-Meng,
Y1 - 2016/05/19/
PY - 2016/02/20/received
PY - 2016/05/17/revised
PY - 2016/05/18/accepted
PY - 2016/6/6/entrez
PY - 2016/6/6/pubmed
PY - 2017/5/10/medline
KW - 4-hydroxyphenyl carvedilol
KW - Carvedilol
KW - Pharmacokinetics
KW - UPLC–MS/MS
KW - Vortioxetine
SP - 184
EP - 190
JF - Journal of pharmaceutical and biomedical analysis
JO - J Pharm Biomed Anal
VL - 128
N2 - To establish a rapid and sensitive ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method for the determination of vortioxetine, carvedilol and its metabolite 4-hydroxyphenyl carvedilol in rat plasma. The analytes and the internal standard (diazepam) were separated on an Acquity UPLC BEH C18 chromatography column (2.1mm×50mm, 1.7μm) using gradient elution with a mobile phase of acetonitrile and 0.1% formic acid in water at a flow rate of 0.4mL/min. The detection was performed on a triple quadrupole tandem mass spectrometer by multiple reaction monitoring (MRM) mode to monitor the precursor-to-product ion transitions of m/z 299.2→150.1 for vortioxetine, m/z 407.2→100.3 for carvedilol, m/z 423.2→100.1 for 4-hydroxyphenyl carvedilol and m/z 285.2→193.1 for diazepam (IS) using a positive electrospray ionization interface. The method was validated over a concentration range of 0.5-100ng/mL for vortioxetine, 0.5-1000ng/mL for carvedilol and 0.1-50ng/mL for 4-hydroxyphenyl carvedilol. Total time for each chromatograph was 3.0min. The intra- and inter-day precision and accuracy of the quality control samples at low, medium, and high concentration levels exhibited relative standard deviations (RSD)<11.6% and the accuracy values ranged from -12.2% to 11.3%. The analytical method was successfully applied to a pharmacokinetic interaction study of vortioxetine and carvedilol after oral administration vortioxetine and carvedilol in rats. Results suggested that the co-administration of vortioxetine and carvedilol results in a significant drug interaction in rats.
SN - 1873-264X
UR - https://www.unboundmedicine.com/medline/citation/27262994/Simultaneous_quantification_of_vortioxetine_carvedilol_and_its_active_metabolite_4_hydroxyphenyl_carvedilol_in_rat_plasma_by_UPLC_MS/MS:_Application_to_their_pharmacokinetic_interaction_study_
DB - PRIME
DP - Unbound Medicine
ER -